About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 4NCT04498455

Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency

A randomized placebo controlled trial to determine if increased dietary fiber will prevent weight gain, inhibit adiposity and reduce perceived stress levels in residents at the Waco Family Health Cent...

Lead sponsor: Baylor University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Baylor University

This study will utilize a single blind, placebo controlled, parallel design to assess the effect of dietary fiber \[Prebiotin\] on the gut microbiome, perceived stress, anthropometric variables, and clinical biomarkers of metabolism. All participants in this study will be resident physicians at the Family Health Center in Waco, TX. This population was selected based on pilot data indicating they are at a greater risk for weight gain and have higher levels of stress than the average population. The goal is to recruit 40 participants for a 12 week intervention trial.

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Currently a resident in training at the Family Health Center in their first year.

Exclusion Criteria

•Pregnancy
•Currently on prescribed metformin or NSAIDS
•A diagnosed gastro-intestinal disease (i.e. irritable bowel syndrome or Crohn's disease)
•Known allergy to the supplement, placebo, or provided meal replacements
•Antibiotic use within the last 3 months.

Related studies

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more

Spinal Cord Injury Model Systems (SCIMS) - Education Module

NCT06003686 · Spinal Cord Injuries, Obesity, and more

Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correlation With Metabolic Syndrome and Insulin-Secreting Cells.

NCT06801769 · Pancreatic Steatosis, Metabolic Syndrome X, and more

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

NCT07237750 · Overweight and/or Obesity, Metabolic Syndrome, and more

Effects of Cranberry on Gut and Metabolic Health

NCT07460856 · Overweight/Obesity, Metabolic Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 17, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment11

Start dateSep 2018

Last updatedAug 17, 2020

Condition

Weight Gain Trajectory Metabolic Syndrome

Locations shown

Baylor University

Waco, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 17, 2020Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions